Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
OptimizeRx Co. stock logo
OPRX
OptimizeRx
$15.05
-1.0%
$10.56
$3.78
$15.71
$281.12M1.34292,587 shs221,530 shs
Paysign, Inc. stock logo
PAYS
Paysign
$5.05
+4.1%
$3.11
$1.80
$5.59
$262.96M0.6230,756 shs345,936 shs
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$10.91
$10.91
$10.35
$11.93
$283.07M-0.0231,316 shsN/A
Veritone, Inc. stock logo
VERI
Veritone
$1.47
-4.5%
$1.88
$1.42
$5.64
$66.58M2.76750,383 shs794,532 shs
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
OptimizeRx Co. stock logo
OPRX
OptimizeRx
-0.99%+6.14%+36.69%+93.69%+28.63%
Paysign, Inc. stock logo
PAYS
Paysign
+4.12%+7.22%+67.22%+107.82%+18.54%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00%0.00%0.00%0.00%0.00%
Veritone, Inc. stock logo
VERI
Veritone
-4.55%-0.68%-20.11%-43.68%-45.15%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
OptimizeRx Co. stock logo
OPRX
OptimizeRx
2.7072 of 5 stars
2.44.00.00.03.43.30.6
Paysign, Inc. stock logo
PAYS
Paysign
4.0157 of 5 stars
3.53.00.00.02.63.32.5
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/AN/AN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
3.1183 of 5 stars
3.40.00.03.33.30.80.0
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
OptimizeRx Co. stock logo
OPRX
OptimizeRx
2.73
Moderate Buy$10.81-28.16% Downside
Paysign, Inc. stock logo
PAYS
Paysign
3.00
Buy$7.0639.85% Upside
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
0.00
N/AN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
2.75
Moderate Buy$4.63214.63% Upside

Current Analyst Ratings Breakdown

Latest VERI, SHAP, OPRX, and PAYS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
6/9/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$12.50 ➝ $16.00
5/14/2025
Paysign, Inc. stock logo
PAYS
Paysign
DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$5.00 ➝ $6.00
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
B. Riley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$8.00 ➝ $12.50
5/13/2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Outperform ➝ Market Outperform$11.00 ➝ $14.00
5/9/2025
Paysign, Inc. stock logo
PAYS
Paysign
Lake Street Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$6.00 ➝ $7.00
5/9/2025
Paysign, Inc. stock logo
PAYS
Paysign
LADENBURG THALM/SH SH
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$7.25 ➝ $8.25
5/9/2025
Veritone, Inc. stock logo
VERI
Veritone
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$3.50 ➝ $2.00
4/28/2025
Veritone, Inc. stock logo
VERI
Veritone
D. Boral Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$4.50 ➝ $4.50
(Data available from 6/13/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
OptimizeRx Co. stock logo
OPRX
OptimizeRx
$94.37M2.95N/AN/A$6.97 per share2.16
Paysign, Inc. stock logo
PAYS
Paysign
$63.79M4.29$0.32 per share15.75$0.46 per share10.98
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/A($0.47) per shareN/A
Veritone, Inc. stock logo
VERI
Veritone
$90.95M0.73N/AN/A$1.03 per share1.43
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
OptimizeRx Co. stock logo
OPRX
OptimizeRx
-$17.57M-$0.84N/AN/AN/A-27.41%-4.92%-3.41%8/6/2025 (Estimated)
Paysign, Inc. stock logo
PAYS
Paysign
$6.46M$0.1133.6717.41N/A14.28%30.64%4.82%7/30/2025 (Estimated)
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
$4.35MN/A0.00N/AN/A-22.17%6.72%N/A
Veritone, Inc. stock logo
VERI
Veritone
-$58.62M-$0.88N/AN/A-47.97%-649.13%-10.32%8/14/2025 (Estimated)

Latest VERI, SHAP, OPRX, and PAYS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/12/2025Q1 2025
OptimizeRx Co. stock logo
OPRX
OptimizeRx
-$0.11$0.08+$0.19-$0.12$18.69 million$21.93 million
5/8/2025Q1 2025
Paysign, Inc. stock logo
PAYS
Paysign
$0.04$0.05+$0.01$0.05$17.49 million$18.60 million
3/25/2025Q4 2024
Paysign, Inc. stock logo
PAYS
Paysign
$0.02$0.02N/A$0.02$15.42 million$15.61 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
OptimizeRx Co. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
Paysign, Inc. stock logo
PAYS
Paysign
N/AN/AN/AN/AN/A
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/AN/AN/AN/AN/A
Veritone, Inc. stock logo
VERI
Veritone
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
OptimizeRx Co. stock logo
OPRX
OptimizeRx
0.29
3.23
3.23
Paysign, Inc. stock logo
PAYS
Paysign
N/A
1.09
1.09
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A
6.19
6.19
Veritone, Inc. stock logo
VERI
Veritone
N/A
0.66
0.66

Institutional Ownership

CompanyInstitutional Ownership
OptimizeRx Co. stock logo
OPRX
OptimizeRx
76.47%
Paysign, Inc. stock logo
PAYS
Paysign
25.89%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
9.94%
Veritone, Inc. stock logo
VERI
Veritone
39.18%

Insider Ownership

CompanyInsider Ownership
OptimizeRx Co. stock logo
OPRX
OptimizeRx
5.60%
Paysign, Inc. stock logo
PAYS
Paysign
22.40%
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
58.40%
Veritone, Inc. stock logo
VERI
Veritone
14.00%
CompanyEmployeesShares OutstandingFree FloatOptionable
OptimizeRx Co. stock logo
OPRX
OptimizeRx
10018.50 million17.30 millionOptionable
Paysign, Inc. stock logo
PAYS
Paysign
8054.22 million41.02 millionOptionable
Spree Acquisition Corp. 1 Limited stock logo
SHAP
Spree Acquisition Corp. 1
N/A25.95 million10.79 millionNot Optionable
Veritone, Inc. stock logo
VERI
Veritone
55045.29 million29.49 millionOptionable

Recent News About These Companies

Q1 2025 Veritone Inc Earnings Call
Veritone Reports First Quarter 2025 Results
How AI can help win the battle for eyeballs

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$15.05 -0.15 (-0.99%)
As of 06/12/2025 04:00 PM Eastern

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Paysign stock logo

Paysign NASDAQ:PAYS

$5.05 +0.20 (+4.12%)
As of 06/12/2025 04:00 PM Eastern

Paysign, Inc. provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card. The company markets its prepaid card solutions under the Paysign brand. Its primary market focus is on companies and municipalities that require a streamlined payment solution for rewards, rebates, payment assistance, and other payments to their customers, employees, agents, and others. The company was formerly known as 3PEA International, Inc. and changed its name to Paysign, Inc. in April 2019. Paysign, Inc. was incorporated in 1995 and is headquartered in Henderson, Nevada.

Spree Acquisition Corp. 1 stock logo

Spree Acquisition Corp. 1 NYSE:SHAP

$10.91 0.00 (0.00%)
As of 06/11/2025

Spree Acquisition Corp. 1 Limited does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the mobility-related technology businesses. The company was incorporated in 2021 and is based in Atlanta, Georgia.

Veritone stock logo

Veritone NASDAQ:VERI

$1.47 -0.07 (-4.55%)
As of 06/12/2025 04:00 PM Eastern

Veritone, Inc., together with its subsidiaries, engages in the provision of artificial intelligence (AI) computing solutions and services in the United States, the United Kingdom, France, Australia, Israel, and India. It develops and operates aiWARE platform, an AI operating system, that uses machine learning algorithms or AI models designed to mimic human cognitive functions, such as perception, prediction, and problem solving and optimization, as well as enables users to transform unstructured data into structured data, and analyze and optimize data to drive business processes and insights. The company also provides media advertising agency services, including media planning and strategy, media buying and placement, campaign messaging, clearance verification and attribution, and custom analytics directly to advertisers through outbound sales networking, and client and partner referrals, as well as indirectly through advertising agencies or marketing consultants. It serves media and entertainment, government, legal and compliance, energy, and other vertical markets. The company was formerly known as Veritone Delaware, Inc. and changed its name to Veritone, Inc. in July 2014. Veritone, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.